---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024726"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2023-07-17T23:59:59+00:00"
generated_at: "2026-06-13T07:27:03.333607+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals dismisses Buchbinder, appoints Mazers as new auditor

## Summary
- Audit Committee approved appointment of Mazers USA LLP on July 11, 2023, effective same day.
- Buchbinder Tunick & Company LLP was dismissed as independent auditor, effective July 12, 2023.
- No disagreements or reportable events with Buchbinder during fiscal years 2022 and 2023 or subsequent interim period.
- Buchbinder's reports for those fiscal years contained no adverse opinion or qualification.

## SEC filing metadata
- accession: 0001493152-23-024726
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2023-07-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315223024726/0001493152-23-024726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315223024726/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024726
- JSON: https://secwatch.observer/filing/0001493152-23-024726.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024726.txt

## Key facts
- Auditor Changes
  ELITE PHARMACEUTICALS INC /NV/ engaged Mazers USA LLP as its auditor.
  - Action: engagement
  - Auditor: Mazers USA LLP
  source text: Company”) approved the appointment, effective July 11, 2023, of Mazers USA LLP (“Mazers”) as the Company’s new independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ending
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053369/000149315223024726/0001493152-23-024726-index.htm
- Auditor Changes
  ELITE PHARMACEUTICALS INC /NV/ dismissed Buchbinder Tunick & Company LLP as its auditor.
  - Action: dismissal
  - Auditor: Buchbinder Tunick & Company LLP
  - Successor: Mazers USA LLP
  source text: The Audit Committee also dismissed Buchbinder Tunick & Company LLP (“Buchbinder”) as the Company’s independent registered public accounting firm, effective as of July 12, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053369/000149315223024726/0001493152-23-024726-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.